Market & Regulation
Takeda partners with Insilico for AI drug discovery
AI Newshigh confidence
Why it matters
- →The partnership highlights the increasing role of AI in pharmaceutical research.
- →It could accelerate the discovery and development of new drug candidates.
- →The deal positions Insilico as a significant player in AI-driven drug discovery.
Takeda has entered a strategic partnership with Insilico Medicine to utilize AI in early-stage drug discovery. The collaboration grants Takeda access to Insilico's Pharma.AI platform, which aids in target identification, molecular design, and clinical trial prediction. The deal could be worth up to $600 million, contingent on achieving various milestones. This partnership reflects Takeda's ongoing efforts to integrate AI into its drug discovery processes, potentially accelerating the development of new therapeutics. Insilico's shares rose following the announcement, indicating market confidence in the collaboration's potential.
Read originalMore in Market & Regulation
© TechCrunch AIMarket & Regulationimage
Meta removes AI feature from Instagram after backlash
Meta has quickly retracted an AI feature from Instagram that allowed users to alter photos from public accounts without notifying the original poster. This feature, part of the Muse Image AI suite developed by Meta Superintelligence Labs, sparked immediate criticism due to its potential for misuse, such as generating unauthorized images. The removal underscores the ongoing struggle tech companies face in aligning innovative tools with user privacy and ethical standards. Meta intended to offer a creative tool, but the absence of user consent mechanisms led to its swift withdrawal, emphasizing the necessity for stronger safeguards in AI technology.
TechCrunch AI
© The Verge AIMarket & Regulationimage
Meta Disables Instagram AI Deepfake Feature
Meta has quickly removed a controversial Instagram feature that allowed users to create AI-generated images using content from public accounts. This feature, part of Meta's Muse Image AI model, faced heavy criticism for enabling potential misuse without the consent of account owners. Critics, including the National Center on Sexual Exploitation, pointed out risks such as sextortion and privacy violations. Initially, Meta offered an opt-out option hidden in settings, but the backlash led to the feature's complete removal. This decision highlights the ongoing challenge for tech companies to innovate while respecting user privacy and safety.
The Verge AI
© The Verge AIMarket & Regulationbusiness
Apple sues OpenAI over alleged trade secret theft
Apple has taken legal action against OpenAI, accusing the company of illicitly acquiring trade secrets to enhance its hardware development. The lawsuit alleges that former Apple employees, now working at OpenAI, transferred confidential information about Apple's unreleased products and processes. This legal conflict reveals the intense competition among tech giants as they venture into AI hardware. If the allegations hold true, OpenAI's hardware plans and its partnerships could face significant challenges. This case brings attention to the vital role of intellectual property protection in the tech industry.
The Verge AI